Not All GLP-1s Are Equal—Here’s What Actually Matters
The Expansion of Telehealth GLP-1 Access
Recent news from Novo Nordisk highlights expanded telehealth access to Wegovy (semaglutide), making FDA-approved GLP-1 medications more widely available through direct-to-patient platforms.
On the surface, this looks like a win: greater access, lower friction, and more patients treated.
And in many ways, it is.
But there’s an important nuance that’s largely being overlooked.
Not All GLP-1 Medications Produce the Same Results
GLP-1 medications are often discussed as if they’re interchangeable. They’re not.
While semaglutide has been a breakthrough for weight loss, it is no longer the most advanced option in this class.
Newer therapies are producing different—and in some cases, more favorable—outcomes.
Why Body Composition Matters More Than Weight Loss Alone
In clinical studies, roughly 40–50% of the weight lost with semaglutide can be due to lean mass—muscle, bone, and other metabolically important tissues.
That includes:
• Muscle
• Bone
• Other metabolically active tissue
That matters because muscle and bone preservation are among the strongest predictors of longevity and healthspan. Weight loss alone is not longevity medicine.
Newer GLP-1 and Dual-Incretin Therapies
Newer medications are changing what’s possible. Tirzepatide, a dual-incretin therapy, has demonstrated greater weight loss in trials and appears to preserve body composition more favorably. And the next-generation drug, retatrutide, may be even more powerful.
Even more advanced therapies, such as retatrutide, are showing early promise in clinical trials by targeting multiple metabolic pathways simultaneously.
The landscape is evolving quickly—and not all options are equal.
The Problem With “$99 GLP-1” Marketing
You’ve likely seen ads promoting “$99 GLP-1s.” Those prices almost always reflect the starter titration dose, not the therapeutic dose most patients ultimately need.
What’s often not disclosed:
• These prices typically reflect introductory or starter doses
• Most patients require higher, therapeutic dosing over time
By the time patients reach effective dosing, monthly costs often fall in the range of $250–$400+, regardless of the specific medication.
So choosing a treatment based on the lowest advertised price is often the wrong question.
What Actually Matters in Medical Weight Loss
The better question is: Which therapy improves metabolic health while preserving muscle and long-term function?
GLP-1 medications are powerful tools. They can:
• Improve A1c
• Lower blood pressure
• Improve lipid profiles
• Reduce overall cardiometabolic risk
But if you’re thinking beyond short-term weight loss—toward longevity and performance—the goal changes.
Fat Loss vs. Muscle Loss: The Real Goal
The objective isn’t simply to lose weight.
It’s to reduce body fat while preserving—or ideally building—muscle, and to maintain the strength, metabolic function, and resilience that support long-term health. Muscle isn’t just cosmetic; it plays a central role in insulin sensitivity, energy expenditure, balance, and overall physical capability.
When weight loss comes at the expense of lean mass, patients may see the number on the scale go down, but they often compromise the very systems that protect against frailty, injury, and metabolic decline over time.
That’s why the goal isn’t just weight reduction—it’s improving body composition in a way that supports strength, function, and longevity.
The Role of a Structured, Physician-Guided Program
Medication alone is not enough. GLP-1 therapies can significantly shift appetite and metabolism, but without a structured plan, patients risk losing lean mass, under-eating protein, or failing to build the habits needed to sustain results long-term.
To optimize outcomes, GLP-1 therapy should be paired with:
• Resistance training
• Adequate protein intake
• Ongoing metabolic monitoring
• Individualized dosing and adjustments
This combination helps ensure that weight loss is driven primarily by fat reduction while preserving the muscle and metabolic function that support long-term health.
This is where many telehealth-only models fall short—offering access to medication without the clinical oversight, data tracking, and lifestyle integration required to achieve optimal results.
Choosing the Right Approach
GLP-1 medications have transformed what’s possible in medical weight loss. But not all medications—and not all programs—are created equal. If your goal is true metabolic health and long-term performance, the focus should be on the right therapy, combined with the right strategy.
Is a GLP-1 Program Right for You?
If you’re considering GLP-1 medications, it’s worth taking a more thoughtful approach—one that looks beyond convenience and price alone.
Start with a comprehensive evaluation and explore a program designed to support not just weight loss, but long-term strength, function, and health.